ELV (Elevance Health, Inc.) is set to announce its Q2'26 results on July 15, after the market closes. The earnings are expected to be disclosed at 6:00 AM ET (10:00 AM UTC).
For Q2'26, revenue estimate is 48.82 billion USD with EPS (earnings per share) anticipated at 6.21 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported49.42 B50.09 B49.31 B49.49 B— | Revenue Estimate48.19 B49.38 B49.84 B48.20 B48.82 B | Revenue Surprise+2.55%+1.43%-1.07%+2.68% | EPS Reported8.846.033.3312.58 | EPS Estimate8.914.933.1010.826.21 | EPS Surprise-0.78%+22.24%+7.54%+16.28% |